학술논문
Non-Randomised, Open Phase II Trial, Investigating Liposomal Irinotecan and 5-Fluorouraci Followed by Surgical Resection in Patients with Hepatic Oligometastatic Pancreatic Cancer (HOLIPANC)
Document Type
Abstract
Author
Source
In European Journal of Surgical Oncology February 2020 46(2):e6-e6
Subject
Language
ISSN
0748-7983